Cerdas-Quesada C

Language: Spanish
References: 17
Page: 14-17
PDF size: 711.10 Kb.

ABSTRACT

The antiglobulin test is the most used technique in immunohematology and detects at least between 200 and 500 molecules of IgG, IgA molecules 120 and 30 molecules per erythrocyte IgM. Maximum intensity is achieved when agglutination of erythrocytes coated with more than 700 molecules over 100 IgA or IgM molecules. This report describes several controversial cases where the test becomes ambiguous meaning in some cases may interfere with the reporting of results and even delivery of units of blood products.

REFERENCES

1. Coombs RRA, Mourant AE, Race RR. Detection of Peak and incomplete Rh agglutinins: a new test. Lancet 1945; II: 15-16.

2. Coombs RRA, Mourant AE, Race RR. In vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946; II: 264-6.

3. Bencomo-Hernández A, Alfonso-Valdés ME. Detección de an- ticuerpos IgA e IgM en la prueba de antiglobulina (Coombs). Revista Cubana de Hematología, Inmunología y Hemoterapia 2010; 26:4-10.

4. Bencomo A, Alfonso M, Valdés O, Alfonso ME. Quantitation of red cell-bound IgG, IgA, and IgM in patients with autoimmune hemolytic anemia and blood donors by enzyme-linked immu- nosorbent assay. Immunohematology 2003:19:47-53.

5. Garraty G. The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction? Transf Med 2008; 18:321-34.

6. Bencomo-Hernández A, Alfonso-Váldez ME, Ávila-Cabrera OM, Espinosa-Martínez E, Jaime-Fagundo JC, Hernández- Ramírez. Relación entre hemólisis con la presencia y cuan- tificación de inmunoglobulinas en hematíes, en la anemia hemolítica autoinmune. Revista Cubana de Hematología, In- munología y Hemoterapia 2010; 26

7. Garraty G. The clinical significance (and insignificance) of red blood cell bound IgG and complement. En Wallace ME, Levitt JS,(eds). Current applications and Interpretation of the Direct Antiglobuline Test. Arlington, VA: American Association of Blood Banks, 1988:1-24.

8. Garraty G. The significance of IgG on the RBC surface. Trans- fus Med Rev 1987; 1:47-57.

9. Toy P, Chin CA, Reid ME. Factors associated with positive direct antiglobuline tests in pretransfusion patients. A case- control study. Vox Sang 1975; 1:47-57.

10. De Figueiredo M, Lima M, Morais S, Porto G, Justicia B. The gel test: some problems and Solutions. Transf Med 1992; 2:115-8.

11. Shanwell A, Sallander S, Bremme K, Westgren M. Clinical eva- luation of a solid-phase test for red cell antibody screening of pregnant women. Transfusion 1999; 39: 26-31.

12. Rottenberg Y, Yahalom V, Shinar E, Barchana M, Adler B, Pal- tiel O. Blood donors with positive direct antiglobulina tests are at increased for cancer. Transfusion 2009; 49: 838-843.

13. Cerdas-Quesada C, Balaguera, A. Incidencia de donaciones de sangre con prueba de antiglobulina directa positiva. Revis- ta Argentina de Transfusión 2012; 38:215-216.

14. Martinengo M, Ardenghi DF, Tripodi G, Reali G. The first case of drug-induced immune hemolytic anemia due to hydrocorti- sone. Transfusion 2008;48:1925-9.

15. Bellia M, Georgopoulos J, Tsevrenis V, Nomikou E, Vgontza N, Kontopoulou-Griva I. The investigation of the significance of a positive direct antiglobulin test in blood donors. Immunohe- matology 2002; 18:78-81.

16. Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972; 12:352-3.

17. Cerdas-Quesada C. La Prueba de Antiglobulina Directa: el dilema entre lo clínicamente significativo y lo no significativo. Revista Argentina de Transfusión 2013; 39:55-61.